Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced

Michael I Carr1, Justine E Roderick2, Hugh S Gannon1

  • 1Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA 01655, USA.

Cell Reports
|August 30, 2016
PubMed

Insights

Phosphorylating Mdm2 at S394 by ATM stabilizes p53, crucial for DNA damage response. This phosphorylation delays lymphoma in mice, but inhibiting it aids bone marrow recovery after radiation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Signaling

Background:

  • ATM-Mdm2 signaling is critical for p53 stabilization and activation following DNA damage.
  • Mdm2 phosphorylation at serine 394 (S394) by ATM is a key regulatory step.
  • The in vivo role of Mdm2-S394 phosphorylation in the DNA damage response and tumorigenesis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the in vivo function of Mdm2-S394 phosphorylation in regulating p53 activity and DNA damage response.
  • To determine the impact of Mdm2-S394 phosphorylation on lymphomagenesis and tumorigenesis.
  • To explore the therapeutic potential of modulating ATM-Mdm2 signaling in cancer and radiation therapy.

Main Methods:

  • Utilized Mdm2(S394A) knockin mice to study the effects of preventing Mdm2-S394 phosphorylation.
  • Assessed p53 stabilization and activation in DNA-damaged cells and lymphatic tissues.
  • Evaluated lymphomagenesis in Eμ-myc transgenic mice crossed with Mdm2(S394A) mice.
  • Analyzed hematopoietic stem and progenitor cell function in irradiated Mdm2(S394A) mice.

Main Results:

  • Mdm2-S394 phosphorylation regulates p53 activity and DNA damage response in lymphatic tissues by modulating Mdm2 stability.
  • Preventing Mdm2-S394 phosphorylation delays lymphomagenesis in Eμ-myc transgenic mice and obviates the need for p53 mutation.
  • Irradiated Mdm2(S394A) mice exhibit increased hematopoietic stem and progenitor cell function and decreased lymphomagenesis.

Conclusions:

  • ATM-mediated Mdm2-S394 phosphorylation plays a dual role in tumor suppression and DNA damage response.
  • Destabilizing Mdm2 via ATM phosphorylation is a potential therapeutic strategy for oncogene-induced malignancies.
  • Inhibiting Mdm2-S394 phosphorylation could mitigate bone marrow failure and prevent secondary malignancies after radiation or chemotherapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K